Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Revenue

Jerusalem Pharmaceuticals had revenue of $12.16M USD in the quarter ending June 30, 2026, with 10.65% growth. This brings the company's total for the last twelve months to $51.36M, up 16.19% year-over-year. In the year 2025, Jerusalem Pharmaceuticals had annual revenue of $48.95M with 22.91% growth. That makes Jerusalem Pharmaceuticals the 27,783rd largest company in the world by revenue and 16th in Palestine.

• Revenue (ttm): $51.36M
• Revenue Growth: +16.19%
• P/S Ratio: 2.37
• Revenue / Employee: $86.32K
• Employees: 595
• Market Cap: 86.26M JOD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Pharmaceutical Sales Sector 48.93M 100.0%
• ALL Other Sectors 19.06K 0.0%

By Geography

Chart

• Palestine 36.95M 75.5%
• Jordan 5.10M 10.4%
• Arabian Gulf 4.80M 9.8%
• Algeria 1.59M 3.2%
• Africa 298.97K 0.6%
• Europe 204.08K 0.4%

Fiscal year ended Dec 31, 2025 See the full Jerusalem Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	48.95M	9.12M	22.91%
Dec 31, 2024	39.82M	168.20K	0.42%
Dec 31, 2023	39.65M	-6.49M	-14.06%
Dec 31, 2022	46.14M	-82.72K	-0.18%
Dec 31, 2021	46.23M	9.83M	27.00%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error